Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.sanjivani.co.in | |
Market Cap | 66.23 Cr. | |
Enterprise Value(EV) | 68.72 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 4.51 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 14.68 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 33.43 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | -3.07 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | -21.55 | Calculated using Price: 66.24 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.00 Cr. | 9,998,300 Shares |
FaceValue | 10 | |
About Sanjivani Paranteral Ltd. | ||
Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the company's products includes oral solids, small volume parenterals and sterile powder formulations. |
1 Day |
|
+4.53% |
1 Week |
|
+15.40% |
1 Month |
|
+25.87% |
3 Month |
|
+102.93% |
6 Month |
|
+71.17% |
1 Year |
|
+31.26% |
2 Year |
|
+518.21% |
5 Year |
|
+1054.00% |
10 Year |
|
+317.11% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 4.66 | -7.19 | -58.98 | -596.93 | ||||||
Return on Capital Employed (%) | 12.18 | 5.69 | -7.28 | -33.04 | -227.28 | -265.98 | 266.43 | |||
Return on Assets (%) | 1.38 | -2.09 | -14.16 | -34.18 | -124.34 | -9.62 | -10.16 | 8.13 | 25.80 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 35 | 32 | 18 | -9 | -53 | -47 | -49 | -45 | -8 | -3 | |
Non Curr. Liab. | 8 | 7 | 14 | 9 | 6 | 10 | 9 | 7 | 4 | 1 | |
Curr. Liab. | 74 | 75 | 62 | 61 | 72 | 56 | 55 | 58 | 22 | 23 | |
Minority Int. | |||||||||||
Equity & Liab. | 117 | 114 | 93 | 60 | 25 | 18 | 16 | 19 | 18 | 21 | |
Non Curr. Assets | 27 | 16 | 23 | 17 | 16 | 11 | 12 | 10 | 11 | 13 | |
Curr. Assets | 90 | 98 | 70 | 43 | 9 | 7 | 4 | 9 | 8 | 8 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 117 | 114 | 93 | 60 | 25 | 18 | 16 | 19 | 18 | 21 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 159 | 133 | 115 | 33 | 18 | 25 | 16 | 25 | 31 | 35 | |
Other Income | 3 | 1 | 1 | 3 | 0 | 1 | 0 | 0 | 2 | 1 | |
Total Income | 161 | 135 | 116 | 36 | 18 | 26 | 17 | 25 | 32 | 36 | |
Total Expenditure | -149 | -128 | -121 | -56 | -70 | -27 | -17 | -23 | -26 | -30 | |
PBIDT | 12 | 7 | -5 | -20 | -52 | -1 | 0 | 2 | 6 | 6 | |
Interest | -8 | -8 | -9 | -5 | 0 | 0 | -1 | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | 0 | ||||||||||
PAT | 2 | -2 | -15 | -26 | -53 | -2 | -2 | 1 | 5 | 5 | |
Adjusted EPS | 3 | -4 | -25 | -44 | -90 | -4 | -3 | 2 | 5 | 5 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 7 | 9 | -1 | 0 | 10 | 3 | 2 | 0 | 1 | 9 | |
Cash Fr. Inv. | -1 | -1 | 9 | -1 | 0 | 0 | 0 | 0 | 0 | -1 | |
Cash Fr. Finan. | -6 | -8 | -7 | -1 | -10 | -3 | -2 | 0 | 0 | -8 | |
Net Change | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Sat, 03 Jun 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ashwani Khemka & Naina Khemka |
Fri, 02 Jun 2023
Intimation To Exchange As Per Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 And Regulation 7 (2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 Company has received disclosure from the following shareholders regarding acquisition of the Shares of the Company : 01. Ashwani Khemka |
Wed, 31 May 2023
Intimation To Exchange As Per Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 And Regulation 7 (2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 Company has received disclosure from the following shareholders regarding acquisition of the Shares of the Company : 01. Ashwani Khemka |
Fri, 02 Jun 2023 |
|
|
|
|
|